Related Experiment Video
Updated: Aug 15, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Large-scale databases in toxicogenomics
1Department of Molecular Sciences, AstraZeneca R&D, Södertälje, S-151 87 Södertälje, Sweden. Hugh.Salter@astrazeneca.com
Abstract:
The use of genomics to improve molecular strategies in safety assessment has immense promise, with increased mechanistic understanding and improved prediction of unknown compounds possible. Several public initiatives in toxicogenomics are now underway, and mechanistic findings are clearly emerging. A number of databases and standards are emerging to support these initiatives. Significant attention to standardization, both for biologic and technical issues, will be necessary for effective community database(s) to be fully operational.
